A Randomized, Open-label, Single Dose, 2-period, 2-sequence, 2-treatment, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects
Latest Information Update: 25 Jan 2021
At a glance
- Drugs Zectivimod (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors LG Chem
Most Recent Events
- 20 Jan 2021 Status changed from not yet recruiting to completed.
- 27 Apr 2020 New trial record